Cypress Capital Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-999
| Closed | -$278K | – | 302 |
|
|
2023
Q1 | $278K | Buy |
999
+100
| +11% | +$27.8K | 0.04% | 254 |
|
|
2022
Q4 | $249K | Buy |
+899
| New | +$249K | 0.04% | 266 |
|
|
2021
Q4 | – | Sell |
-888
| Closed | -$251K | – | 323 |
|
|
2021
Q3 | $251K | Sell |
888
-2,444
| -73% | -$691K | 0.03% | 249 |
|
|
2021
Q2 | $1.15M | Sell |
3,332
-757
| -19% | -$262K | 0.16% | 127 |
|
|
2021
Q1 | $1.14M | Buy |
4,089
+548
| +15% | +$153K | 0.16% | 126 |
|
|
2020
Q4 | $867K | Sell |
3,541
-904
| -20% | -$221K | 0.13% | 138 |
|
|
2020
Q3 | $1.26M | Buy |
4,445
+101
| +2% | +$28.7K | 0.21% | 110 |
|
|
2020
Q2 | $1.16M | Buy |
4,344
+2,717
| +167% | +$727K | 0.21% | 106 |
|
|
2020
Q1 | $514K | Buy |
1,627
+51
| +3% | +$16.1K | 0.12% | 122 |
|
|
2019
Q4 | $468K | Sell |
1,576
-337
| -18% | -$100K | 0.08% | 154 |
|
|
2019
Q3 | $446K | Buy |
1,913
+432
| +29% | +$101K | 0.09% | 162 |
|
|
2019
Q2 | $347K | Sell |
1,481
-990
| -40% | -$232K | 0.07% | 182 |
|
|
2019
Q1 | $584K | Sell |
2,471
-179
| -7% | -$42.3K | 0.12% | 143 |
|
|
2018
Q4 | $797K | Buy |
2,650
+445
| +20% | +$134K | 0.18% | 111 |
|
|
2018
Q3 | $779K | Buy |
2,205
+340
| +18% | +$120K | 0.15% | 128 |
|
|
2018
Q2 | $542K | Buy |
1,865
+105
| +6% | +$30.5K | 0.11% | 150 |
|
|
2018
Q1 | $482K | Buy |
1,760
+319
| +22% | +$87.4K | 0.1% | 153 |
|
|
2017
Q4 | $459K | Buy |
1,441
+33
| +2% | +$10.5K | 0.1% | 158 |
|
|
2017
Q3 | $441K | Buy |
1,408
+639
| +83% | +$200K | 0.09% | 157 |
|
|
2017
Q2 | $209K | Buy |
+769
| New | +$209K | 0.05% | 198 |
|